These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 39126829)

  • 1. Attitudes of pregnant women in the Dominican Republic towards a future maternal Group B Streptococcus vaccine.
    Job MJ; Kim D; Acosta F; Valera S; Fernandez A; Laycock KM; Ratner AJ; Steenhoff AP; Feemster K; Geoghegan S
    Vaccine; 2024 Sep; 42(22):126169. PubMed ID: 39126829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparing for Group B
    Geoghegan S; Faerber J; Stephens L; Gillan H; Drew RJ; Eogan M; Feemster KA; Butler KM
    Hum Vaccin Immunother; 2023 Dec; 19(1):2195331. PubMed ID: 37036198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing women's attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey.
    McQuaid F; Jones C; Stevens Z; Plumb J; Hughes R; Bedford H; Voysey M; Heath PT; Snape MD
    BMJ Open; 2016 Apr; 6(4):e010790. PubMed ID: 27098824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnant women's knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines.
    Giles ML; Buttery J; Davey MA; Wallace E
    Vaccine; 2019 Oct; 37(44):6743-6749. PubMed ID: 31540809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of a hypothetical group B strep vaccine among pregnant and recently delivered women.
    Dempsey AF; Pyrzanowski J; Donnelly M; Brewer S; Barnard J; Beaty BL; Mazzoni S; O'Leary ST
    Vaccine; 2014 May; 32(21):2463-8. PubMed ID: 24662708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes towards antenatal vaccination, Group B streptococcus and participation in clinical trials: Insights from focus groups and interviews of parents and healthcare professionals.
    McQuaid F; Pask S; Locock L; Davis E; Stevens Z; Plumb J; Snape MD
    Vaccine; 2016 Jul; 34(34):4056-61. PubMed ID: 27318418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternity care provider acceptance of a future Group B Streptococcus vaccine - A qualitative study in three countries.
    Geoghegan S; Acosta F; Stephens LC; Gillan H; Valera S; Drew RJ; Eogan M; Ratner AJ; Steenhoff AP; Butler KM; Feemster KA
    Vaccine; 2023 Mar; 41(12):2013-2021. PubMed ID: 36803900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal vaccination against Group B streptococcus: attitudes of pregnant women and healthcare professionals in the UK towards participation in clinical trials and routine implementation.
    McQuaid F; Jones C; Stevens Z; Meddaugh G; O'Sullivan C; Donaldson B; Hughes R; Ford C; Finn A; Faust SN; Gbesemete D; Bedford H; Hughes S; Varghese AS; Heath PT; Snape MD
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):330-340. PubMed ID: 29292509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a potential group B streptococcal vaccine for pregnant women in the United States.
    Kim SY; Nguyen C; Russell LB; Tomczyk S; Abdul-Hakeem F; Schrag SJ; Verani JR; Sinha A
    Vaccine; 2017 Oct; 35(45):6238-6247. PubMed ID: 28951085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial.
    Madhi SA; Cutland CL; Jose L; Koen A; Govender N; Wittke F; Olugbosi M; Meulen AS; Baker S; Dull PM; Narasimhan V; Slobod K
    Lancet Infect Dis; 2016 Aug; 16(8):923-34. PubMed ID: 27139805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of maternal immunisation against group B Streptococcus (GBS) disease: A modelling study.
    Giorgakoudi K; O'Sullivan C; Heath PT; Ladhani S; Lamagni T; Ramsay M; Al-Janabi H; Trotter C
    Vaccine; 2018 Nov; 36(46):7033-7042. PubMed ID: 30293765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for maternal immunization against Group B Streptococcus disease: WHO perspectives on case ascertainment and case definitions.
    Seale AC; Baker CJ; Berkley JA; Madhi SA; Ordi J; Saha SK; Schrag SJ; Sobanjo-Ter Meulen A; Vekemans J
    Vaccine; 2019 Aug; 37(35):4877-4885. PubMed ID: 31303524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.
    Hillier SL; Ferrieri P; Edwards MS; Ewell M; Ferris D; Fine P; Carey V; Meyn L; Hoagland D; Kasper DL; Paoletti LC; Hill H; Baker CJ
    Clin Infect Dis; 2019 May; 68(12):2079-2086. PubMed ID: 30281066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferences of pregnant women toward a future maternal Group B Streptococcus vaccine in China: A cross-sectional survey with a discrete choice experiment.
    Du J; Ji W; Zhao H; McIver DJ; Zhao Y; Chang J; Fang Y
    Hum Vaccin Immunother; 2023 Dec; 19(3):2281713. PubMed ID: 38175949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination for Group B Streptococcus during pregnancy: attitudes and concerns of women and health care providers.
    Patten S; Vollman AR; Manning SD; Mucenski M; Vidakovich J; Davies HD
    Soc Sci Med; 2006 Jul; 63(2):347-58. PubMed ID: 16545514
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Limaye RJ; Singh P; Fesshaye B; Lee C; Schue J; Karron RA
    Hum Vaccin Immunother; 2024 Dec; 20(1):2314826. PubMed ID: 38345050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal GBS vaccination for preventing group B streptococcus disease in newborns: A mini review of current evidence.
    Kokori E; Olatunji G; Komolafe R; Ogieuhi IJ; Oyebiyi B; Ajayi I; Muogbo I; Ukoaka B; Samuel O; Aderinto N
    Int J Gynaecol Obstet; 2024 Aug; 166(2):639-643. PubMed ID: 38445529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial.
    Heyderman RS; Madhi SA; French N; Cutland C; Ngwira B; Kayambo D; Mboizi R; Koen A; Jose L; Olugbosi M; Wittke F; Slobod K; Dull PM
    Lancet Infect Dis; 2016 May; 16(5):546-555. PubMed ID: 26869376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing a serocorrelate of protection against invasive group B streptococcus disease in pregnant women: a feasibility study.
    Carreras-Abad C; Cochet M; Hall T; Ramkhelawon L; Khalil A; Peregrine E; Vinayakarao L; Sivarajan S; Hamid R; Planche T; Sheridan E; Winchester S; Plumb J; Djennad A; Andrews N; Le Doare K; Heath P
    Health Technol Assess; 2019 Dec; 23(67):1-40. PubMed ID: 31855555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa.
    Kim SY; Russell LB; Park J; Verani JR; Madhi SA; Cutland CL; Schrag SJ; Sinha A
    Vaccine; 2014 Apr; 32(17):1954-63. PubMed ID: 24530145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.